Is Benlysta a good drug for Lupus?

Benlysta (belimumab) is an FDA-approved medication specifically for treating systemic lupus erythematosus (SLE) and is shown to be effective in reducing disease activity and flares in some patients. Its use can be beneficial for individuals who have not responded adequately to standard therapies. However, its effectiveness can vary from person to person, and it may not be suitable for everyone. Patients should discuss the potential benefits and risks with their healthcare provider to determine if Benlysta is a good option for their specific situation.